These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 8984302

  • 1. ["The amphetamine treatment helped my child". Is it time to reevaluate Swedish practice in hyperactivity syndrome?].
    Lakartidningen; 1996 Nov 20; 93(47):4307-8. PubMed ID: 8984302
    [No Abstract] [Full Text] [Related]

  • 2. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
    Cox DJ, Merkel RL, Moore M, Thorndike F, Muller C, Kovatchev B.
    Pediatrics; 2006 Sep 20; 118(3):e704-10. PubMed ID: 16950962
    [Abstract] [Full Text] [Related]

  • 3. [Lack of respect for pediatric neuropsychiatry as a field of knowledge].
    Fernell E, Dahlström K.
    Lakartidningen; 2001 May 23; 98(21):2646. PubMed ID: 11434002
    [No Abstract] [Full Text] [Related]

  • 4. Managing attention-deficit/hyperactivity disorder in primary care: a systematic analysis of roles and challenges.
    Power TJ, Mautone JA, Manz PH, Frye L, Blum NJ.
    Pediatrics; 2008 Jan 23; 121(1):e65-72. PubMed ID: 18166546
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Apropos the National Board and Welfare's report on ADDH: some views on the treatment with central nervous system stimulants].
    Zetterström R.
    Lakartidningen; 2002 Aug 29; 99(35):3435-6. PubMed ID: 12362770
    [No Abstract] [Full Text] [Related]

  • 7. [Treatment with central nervous system stimulants. Practical guidelines].
    Hvolby A, Jørgensen JI.
    Ugeskr Laeger; 2004 Jan 12; 166(3):144-8. PubMed ID: 14870640
    [No Abstract] [Full Text] [Related]

  • 8. Innovations in attention-deficit/hyperactivity disorder pharmacotherapy: long-acting stimulant and nonstimulant treatments.
    Stein MA.
    Am J Manag Care; 2004 Jul 12; 10(4 Suppl):S89-98. PubMed ID: 15352535
    [Abstract] [Full Text] [Related]

  • 9. Flawed attention-deficit/hyperactivity disorder medication comparison.
    Adesman A.
    Pediatrics; 2004 Oct 12; 114(4):1132; author reply 1132-3. PubMed ID: 15466129
    [No Abstract] [Full Text] [Related]

  • 10. [Attention deficit disorder with hyperactivity (ADHD). Continuing symptom control with medium term methylphenidate treatment].
    Oberpichler-Schwenk H.
    Med Monatsschr Pharm; 2006 Nov 12; 29(11):415-6. PubMed ID: 17131689
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cardiovascular safety of medication treatments for attention-deficit/hyperactivity disorder.
    Newcorn JH, Donnelly C.
    Mt Sinai J Med; 2009 Apr 12; 76(2):198-203. PubMed ID: 19306385
    [No Abstract] [Full Text] [Related]

  • 13. [Prescribing of stimulants for ADHD in Nordland County].
    Asheim H, Nilsen KB, Johansen K, Furu K.
    Tidsskr Nor Laegeforen; 2007 Sep 20; 127(18):2360-2. PubMed ID: 17895938
    [Abstract] [Full Text] [Related]

  • 14. Cardiovascular monitoring and stimulant drugs for attention-deficit/hyperactivity disorder.
    Perrin JM, Friedman RA, Knilans TK, Black Box Working Group, Section on Cardiology and Cardiac Surgery.
    Pediatrics; 2008 Aug 20; 122(2):451-3. PubMed ID: 18676566
    [No Abstract] [Full Text] [Related]

  • 15. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
    Quintana H, Cherlin EA, Duesenberg DA, Bangs ME, Ramsey JL, Feldman PD, Allen AJ, Kelsey DK.
    Clin Ther; 2007 Jun 20; 29(6):1168-77. PubMed ID: 17692731
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Do typical clinical doses of methylphenidate cause tics in children treated for attention-deficit hyperactivity disorder?
    Killeen MR.
    J Child Fam Nurs; 2000 Jun 20; 3(1):46-8. PubMed ID: 11022478
    [No Abstract] [Full Text] [Related]

  • 19. Evaluation of attention deficit hyperactivity disorder.
    Frazier JP, Barratt MS, Smith KC.
    J Pediatr Health Care; 1999 Jun 20; 13(5):250-3. PubMed ID: 10776202
    [No Abstract] [Full Text] [Related]

  • 20. Outcomes after accidental pediatric ingestions of (dextro)amphetamine and methylphenidate.
    LoVecchio F, Ozimek J, Sawyers B, Thole D.
    Am J Emerg Med; 2009 Oct 20; 27(8):933-4. PubMed ID: 19857410
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.